Results 51 to 60 of about 70 (70)

Kinase inhibition in autoimmunity and inflammation

Nature Reviews Drug Discovery, 2021
Ali A Zarrin, Bruno Hochhegger, Katherine Bao   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Taofeek K Owonikoko, Fadlo R Khuri   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Barata, Brian I Rini
exaly  

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors

Ca-A Cancer Journal for Clinicians, 2011
Kiran K Turaga
exaly  

Kinase inhibitors: the road ahead

Nature Reviews Drug Discovery, 2018
Fleur M Ferguson, Nathanael S Gray
exaly  

New Promise and Opportunities for Allosteric Kinase Inhibitors

Angewandte Chemie - International Edition, 2020
Xiaoyun Lu, Jeff B Smaill, Ke Ding
exaly  

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

Nature Reviews Drug Discovery, 2020
Lauren Mifflin, Junying Yuan
exaly  

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

Nature Reviews Drug Discovery, 2011
Kyle L Kolaja
exaly  

Rho kinase, a promising drug target for neurological disorders

Nature Reviews Drug Discovery, 2005
Nicole Teusch
exaly  

Targeting innate immunity protein kinase signalling in inflammation

Nature Reviews Drug Discovery, 2009
Matthias Gaestel, Michael Kracht
exaly